BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 17436510)

  • 21. [Prevalence of intraepithelial lesion in cervical screening cytology in a First-level Care Unit].
    Solís JG; Briones-Torres TI
    Rev Med Inst Mex Seguro Soc; 2018; 56(2):167-172. PubMed ID: 29902371
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Five-Year Cervical (Pre)Cancer Risk of Women Screened by HPV and Cytology Testing.
    Uijterwaal MH; Polman NJ; Van Kemenade FJ; Van Den Haselkamp S; Witte BI; Rijkaart D; Berkhof J; Snijders PJ; Meijer CJ
    Cancer Prev Res (Phila); 2015 Jun; 8(6):502-8. PubMed ID: 25776933
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Health technology assessment report. Use of liquid-based cytology for cervical cancer precursors screening].
    Ronco G; Confortini M; Maccallini V; Naldoni C; Segnan N; Sideri M; Zappa M; Zorzi M; Calvia M; Giorgi Rossi P
    Epidemiol Prev; 2012; 36(5 Suppl 2):e1-e33. PubMed ID: 23139163
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Progression of 189 women diagnosed with uterine cervical dysplasia based on abnormal results in mass screening.
    Muramatsu T; Yoshitake T; Iida T; Yamashita E; Hirasawa T; Miyamoto T; Murakami M; Matsui N; Kajiwara H; Yasuda M; Osamura RY; Mikami M
    Tokai J Exp Clin Med; 2006 Dec; 31(4):141-5. PubMed ID: 21302243
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Invasive cervical cancer audit: a relative increase in interval cancers while coverage increased and incidence declined.
    Herbert A; Anshu ; Gregory M; Gupta SS; Singh N
    BJOG; 2009 May; 116(6):845-53. PubMed ID: 19432575
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk of high-grade cervical dysplasia and gynaecological malignancies following the cytologic diagnosis of atypical endocervical cells of undetermined significance: a retrospective study of a state-wide screening population in Western Australia.
    Munro A; Williams V; Semmens J; Leung Y; Stewart CJ; Codde J; Spilsbury K; Steel N; Cohen P; O'leary P
    Aust N Z J Obstet Gynaecol; 2015 Jun; 55(3):268-73. PubMed ID: 26044565
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of high-risk human papillomavirus types and cervical squamous intraepithelial lesions in women over 30 years of age in St. Petersburg, Russia.
    Shipitsyna E; Zolotoverkhaya E; Kuevda D; Nasonova V; Romanyuk T; Khachaturyan A; Orlova O; Abashova E; Kostyuchek I; Shipulina O; Anttila A; Savicheva A
    Cancer Epidemiol; 2011 Apr; 35(2):160-4. PubMed ID: 20884314
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial.
    Ronco G; Giorgi-Rossi P; Carozzi F; Confortini M; Dalla Palma P; Del Mistro A; Ghiringhello B; Girlando S; Gillio-Tos A; De Marco L; Naldoni C; Pierotti P; Rizzolo R; Schincaglia P; Zorzi M; Zappa M; Segnan N; Cuzick J;
    Lancet Oncol; 2010 Mar; 11(3):249-57. PubMed ID: 20089449
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk Stratification Using Human Papillomavirus Testing among Women with Equivocally Abnormal Cytology: Results from a State-Wide Surveillance Program.
    Gage JC; Hunt WC; Schiffman M; Katki HA; Cheung LC; Cuzick J; Myers O; Castle PE; Wheeler CM;
    Cancer Epidemiol Biomarkers Prev; 2016 Jan; 25(1):36-42. PubMed ID: 26518316
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of cervical cytological screening results between postmenopausal and elderly women.
    Cakmak B; Köseoğlu DR
    Turk Patoloji Derg; 2014; 30(1):38-42. PubMed ID: 24448705
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rate of cervical cancer, severe intraepithelial neoplasia, and adenocarcinoma in situ in primary HPV DNA screening with cytology triage: randomised study within organised screening programme.
    Anttila A; Kotaniemi-Talonen L; Leinonen M; Hakama M; Laurila P; Tarkkanen J; Malila N; Nieminen P
    BMJ; 2010 Apr; 340():c1804. PubMed ID: 20423964
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cervical cytopathological changes in pregnancy: An experience from a low resource setting.
    Rasheed FA; Yakasai IA; Takai IU; Yusuf I; Ibrahim UM
    Ann Afr Med; 2021; 20(3):212-221. PubMed ID: 34558451
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cervical Cancer Screening of Adolescents and Young Women: Further Evidence Shows a Lack of Clinical Value.
    Campaner AB; Fernandes GL
    J Pediatr Adolesc Gynecol; 2021 Feb; 34(1):6-11. PubMed ID: 33130243
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does screening for cervical intra-epithelial neoplasm in developing countries prevent invasive cervical cancer?
    Okewole IA; Fawole AO; Omigbodun AO; Adewole IF
    Afr J Med Med Sci; 2003 Sep; 32(3):283-5. PubMed ID: 15030089
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Screening histories of women with CIN 2/3 compared with women diagnosed with invasive cervical cancer: a retrospective analysis of the Norwegian Coordinated Cervical Cancer Screening Program.
    Nygård JF; Nygård M; Skare GB; Thoresen SØ
    Cancer Causes Control; 2005 May; 16(4):463-74. PubMed ID: 15953989
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Analysis of cervical cancer screening results in women aged 50 and older in Beijing and Guizhou].
    Guo GZ; Zhao Y
    Zhonghua Zhong Liu Za Zhi; 2018 Dec; 40(12):922-926. PubMed ID: 30605984
    [No Abstract]   [Full Text] [Related]  

  • 37. How many cervical cancer cases can potentially be prevented using a more sensitive screening test at young age?
    de Kok IM; van Rosmalen J; Rozemeijer K; Penning C; van Ballegooijen M
    Int J Cancer; 2014 Jan; 134(2):460-6. PubMed ID: 23824905
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Description of a seven-year prospective study of human papillomavirus infection and cervical neoplasia among 10000 women in Guanacaste, Costa Rica,
    Bratti MC; Rodríguez AC; Schiffman M; Hildesheim A; Morales J; Alfaro M; Guillén D; Hutchinson M; Sherman ME; Eklund C; Schussler J; Buckland J; Morera LA; Cárdenas F; Barrantes M; Pérez E; Cox TJ; Burk RD; Herrero R
    Rev Panam Salud Publica; 2004 Feb; 15(2):75-89. PubMed ID: 15030652
    [TBL] [Abstract][Full Text] [Related]  

  • 39. No. 385-Indications for Pelvic Examination.
    Evans D; Goldstein S; Loewy A; Altman AD
    J Obstet Gynaecol Can; 2019 Aug; 41(8):1221-1234. PubMed ID: 31331610
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pooled analysis of the performance of liquid-based cytology in population-based cervical cancer screening studies in China.
    Pan QJ; Hu SY; Zhang X; Ci PW; Zhang WH; Guo HQ; Cao J; Zhao FH; Lytwyn A; Qiao YL
    Cancer Cytopathol; 2013 Sep; 121(9):473-82. PubMed ID: 23907807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.